Ontology highlight
ABSTRACT: Importance
Melanoma in situ (MIS) is increasing in incidence, and expert consensus opinion recommends surgical excision for therapeutic management. Currently, wide local excision (WLE) is the standard of care. However, Mohs micrographic surgery (MMS) is now used to treat a growing subset of individuals with MIS. During MMS, unlike WLE, the entire cutaneous surgical margin is evaluated intraoperatively for tumor cells.Objective
To assess the outcomes of patients with MIS treated with MMS compared with those treated with WLE.Design, setting, and participants
Retrospective review of a prospective database. The study cohort consisted of 662 patients with MIS treated with MMS or WLE per standard of care in dermatology and surgery (general surgery, otolaryngology, plastics, oculoplastics, surgical oncology) at an academic tertiary care referral center from January 1, 1978, to December 31, 2013, with follow-up through 2015.Exposure
Mohs micrographic surgery or WLE.Main outcomes and measures
Recurrence, overall survival, and melanoma-specific survival.Results
There were 277 patients treated with MMS (mean [SD] age, 64.0 [13.1] years; 62.1% male) and 385 treated with WLE (mean [SD] age, 58.5 [15.6] years; P?Conclusions and relevanceNo significant differences were found in the recurrence rate, overall survival, or melanoma-specific survival of patients with MIS treated with MMS compared with WLE.
SUBMITTER: Nosrati A
PROVIDER: S-EPMC5817486 | biostudies-literature | 2017 May
REPOSITORIES: biostudies-literature
Nosrati Adi A Berliner Jacqueline G JG Goel Shilpa S McGuire Joseph J Morhenn Vera V de Souza Juliana R JR Yeniay Yildiray Y Singh Rasnik R Lee Kristina K Nakamura Mio M Wu Rachel R RR Griffin Ann A Grimes Barbara B Linos Eleni E Chren Mary Margaret MM Grekin Roy R Wei Maria L ML
JAMA dermatology 20170501 5
<h4>Importance</h4>Melanoma in situ (MIS) is increasing in incidence, and expert consensus opinion recommends surgical excision for therapeutic management. Currently, wide local excision (WLE) is the standard of care. However, Mohs micrographic surgery (MMS) is now used to treat a growing subset of individuals with MIS. During MMS, unlike WLE, the entire cutaneous surgical margin is evaluated intraoperatively for tumor cells.<h4>Objective</h4>To assess the outcomes of patients with MIS treated w ...[more]